Concepedia

Tim Wartewig

TW

7

Publications

507

Citations

7

H-Index

2017

Active since

Affiliations

Technical University of Munich(Current)

Deutschen Konsortium für Translationale Krebsforschung

German Cancer Research Center

German Center for Infection Research

Klinikum rechts der Isar

Tim Wartewig is an author at Technical University of Munich specializing in autoimmunity, medicine, and immunology.

ORCID

Top concepts

Publications per year

2017–2023

7

Publications

7

PD-1 is a haploinsufficient suppressor of T cell lymphomagenesis

Tim Wartewig, Zsuzsanna Kurgyis, Selina J. Keppler et al. · Nature · 2017 · 243 citations · Full text

, , +4

Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneity

Joonhee Park, Jay Daniels, Tim Wartewig et al. · Blood · 2021 · 89 citations · Full text

PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma

Tim Wartewig, Jay Daniels, Miriam Schulz et al. · Nature Cancer · 2023 · 47 citations · Full text

Foxp1 controls mature B cell survival and the development of follicular and B-1 B cells

Thomas Patzelt, Selina J. Keppler, Oliver Gorka et al. · Proceedings of the National Academy of Sciences · 2018 · 44 citations · Full text

The uric acid crystal receptor Clec12A potentiates type I interferon responses

Kai Li, Konstantin Neumann, Vikas Duhan et al. · Proceedings of the National Academy of Sciences · 2019 · 44 citations · Full text

Rows per page

1–5 of 7